B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

August 5, 2020

Advances in Regulating Tumorigenicity and Metastasis of Cancer through TrkB Signaling

Current Cancer Drug Targets
Wujun ZouLiang Jiang
August 5, 2020

Tumor lysis syndrome: still the Achilles heel of venetoclax in treatment of CLL?

Leukemia & Lymphoma
Mary Ann Anderson, John Francis Seymour
August 1, 2020
Review

Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis

The Cochrane Database of Systematic Reviews
Nina KreuzbergerNicole Skoetz
August 5, 2020
Open Access

MethylResolver-a method for deconvoluting bulk DNA methylation profiles into known and unknown cell contents

Communications Biology
Douglas ArnesonKai Wang
August 2, 2020
Open Access

Characterizing Chemotherapy-Induced Neutropenia and Monocytopenia Through Mathematical Modelling

Bulletin of Mathematical Biology
Tyler CassidyMichael C Mackey
July 31, 2020
Open Access

Prognostic Value of CXCR2 in Breast Cancer

Cancers
Florence Boissière-MichotGwendal Lazennec
July 31, 2020
Preprint
Open Access

CD20 as a gatekeeper of the resting stage of human B cells

BioRxiv : the Preprint Server for Biology
K. KlasenerMichael Reth
August 4, 2020

A COVID-19 patient with repeatedly undetectable SARS-CoV-2 antibodies

The Journal of Applied Laboratory Medicine
Lianna GoetzYusheng Zhu
August 7, 2020

Association of BTLA rs1982809 polymorphism with lung cancer risk in Tunisian population

International Journal of Immunogenetics
Chaima KhadhraouiAgnes Hamzaoui
August 5, 2020

Integrated mechanistic model of minimal residual disease kinetics with venetoclax therapy in chronic lymphocytic leukemia

Clinical Pharmacology and Therapeutics
Sathej GopalakrishnanKevin J Freise
August 2, 2020

Targeted Next Generation Sequencing Reveals Molecular Heterogeneity in non-CLL Clonal B-Cell Lymphocytosis

Hematological Oncology
Irene DefrancescoLuca Arcaini

Sign up to follow this feed and discover related papers.

Related Feeds

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.

Anthracycline Sensitivity & Chromatin (Keystone)

Anthracyclines are used in the treatment of cancer and work by inhibiting topoisomerase II (TOP2). Recent evidence suggests that because DNA accessibility is crucial for TOP2 binding, chromatin regulatory genes should predict anthracycline response. Find the latest research on anthracycline sensitivity and chromatin regulators in this feed.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics and Chemical Tools (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Using novel chemical tools allows us to learn more about these epigenetic changes and how they impact the neoplastic process. Follow this feed to learn more about cancer epigenetics and chemical tools.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

© 2020 Meta ULC. All rights reserved
/feed-previews/b-cell-leukemia-keystone/e5e66ccc-f234-4039-b472-004df1364d28